Summary

Persistence Market Research has recently published an extensive report on the global Vagus Nerve Stimulation (VNS) Devices Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Vagus Nerve Stimulation Market Size (2024E): USD 565.9 Mn
• Projected Market Value (2031F): USD 783.1 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Vagus Nerve Stimulation Devices Market - Report Scope:

The Vagus Nerve Stimulation (VNS) Market encompasses a variety of devices used in neurological treatments, particularly in managing conditions like epilepsy and depression. These devices are designed to stimulate the vagus nerve using electrical pulses, providing therapeutic benefits for patients who may not respond well to traditional medical treatments. The market is growing due to increasing adoption of non-invasive treatments, advancements in VNS technology, and the expansion of applications in various healthcare settings, including hospitals, clinics, and home care. Growth is driven by the rising incidence of neurological disorders, especially in regions with advanced healthcare infrastructure.

Market Growth Drivers:

The global Vagus Nerve Stimulation Devices Market is driven by several key factors, including the increasing prevalence of neurological disorders like epilepsy and depression. The demand for non-invasive treatment options and advancements in VNS technology, such as the integration of AI and personalized therapy solutions, further propel market growth. Additionally, expanding applications of VNS therapy to conditions beyond epilepsy and depression, such as chronic migraines and obesity, is accelerating the demand for these devices. The rising awareness of VNS benefits in treating resistant cases of neurological disorders is also boosting market penetration in developed regions.

Market Restraints:

Despite its growth potential, the VNS Market faces challenges. Limited awareness among healthcare providers and patients regarding the benefits of VNS therapy hinders market growth, especially in regions where traditional medical treatments are preferred. The high cost of advanced VNS devices, particularly implantable ones, also limits their adoption in price-sensitive markets. Moreover, concerns about the invasiveness of certain VNS devices and the lack of standardization across regions create barriers to market expansion.

Market Opportunities:

The Vagus Nerve Stimulation Market offers significant growth potential, particularly in emerging markets where the prevalence of neurological disorders is rising. Expanding access to VNS therapy through telemedicine and digital health platforms provides an opportunity to enhance patient care in remote areas. Strategic collaborations with healthcare providers and government initiatives aimed at improving healthcare infrastructure further support market expansion. Additionally, the development of non-invasive and cost-effective VNS devices for home care settings provides a new avenue for market growth, catering to the growing demand for at-home neurological treatments.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Vagus Nerve Stimulation Devices Market globally?
• Which types and formats of VNS devices are leading the adoption in various healthcare settings?
• How are technological advancements influencing the competitive landscape of the VNS Market?
• Who are the key players in the Vagus Nerve Stimulation Devices Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global VNS Devices Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Vagus Nerve Stimulation Devices Market focus on product innovation and strategic partnerships to stay competitive. These companies invest in research and development to improve the functionality and efficacy of VNS devices, with a particular emphasis on expanding the range of therapeutic applications. Collaborations with healthcare providers and government bodies help increase the adoption of VNS therapy, especially in developed markets with high healthcare spending. Marketing strategies focused on patient education and raising awareness about the benefits of VNS therapy are crucial for fostering market growth.

Key Market Players

• Soterix Medical Inc.
• MicroTransponder Inc
• Beijing PINS Medical Co., Ltd
• LivaNova PLC
• Neuropix Company Ltd.
• Parasym Ltd
• electroCore, Inc.
• tVNS Health GmbH
• SetPoint Medical Corporation

Vagus Nerve Stimulation Industry Segmentation

By Product

• Implantable VNS Device
• External VNS Device

By Biomaterial

• Metallic
• Ceramics
• Polymeric

By Application

• Epilepsy
• Depression
• Migraine

By Region

• North America
• Latin America
• Europe
• South Asia & Oceania
• East Asia
• The Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Vagus Nerve Stimulation Market Snapshot, 2024-2031
1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Technology Assessment
3.3. Regulatory Landscape
3.4. Value Chain Analysis
3.5. Key Deals and Mergers
3.6. PESTLE Analysis
3.7. Porter’s Five Force Analysis
4. Price Trend Analysis, 2019-2031
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product
4.4. Regional Prices and Product Preferences
5. Global Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
5.3. Global Vagus Nerve Stimulation Market Outlook: Product
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2023
5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
5.3.3.1. Implantable VNS Device
5.3.3.2. External VNS Device
5.4. Market Attractiveness Analysis: Product
5.5. Global Vagus Nerve Stimulation Market Outlook: Biomaterial
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Biomaterial, 2019-2023
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
5.5.3.1. Metallic
5.5.3.2. Ceramics
5.5.3.3. Polymeric
5.6. Market Attractiveness Analysis: Biomaterial
5.7. Global Vagus Nerve Stimulation Market Outlook: Application
5.7.1. Introduction / Key Findings
5.7.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
5.7.3.1. Epilepsy
5.7.3.2. Depression
5.7.3.3. Migraine
5.8. Market Attractiveness Analysis: Application
6. Global Vagus Nerve Stimulation Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2024-2031
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
7.3.1. By Country
7.3.2. By Product
7.3.3. By Biomaterial
7.3.4. By Application
7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
7.5.1. Implantable VNS Device
7.5.2. External VNS Device
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
7.6.1. Metallic
7.6.2. Ceramics
7.6.3. Polymeric
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
7.7.1. Epilepsy
7.7.2. Depression
7.7.3. Migraine
7.8. Market Attractiveness Analysis
8. Europe Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
8.3.1. By Country
8.3.2. By Product
8.3.3. By Biomaterial
8.3.4. By Application
8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Turkey
8.4.8. Rest of Europe
8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
8.5.1. Implantable VNS Device
8.5.2. External VNS Device
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
8.6.1. Metallic
8.6.2. Ceramics
8.6.3. Polymeric
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
8.7.1. Epilepsy
8.7.2. Depression
8.7.3. Migraine
8.8. Market Attractiveness Analysis
9. East Asia Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
9.3.1. By Country
9.3.2. By Product
9.3.3. By Biomaterial
9.3.4. By Application
9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
9.5.1. Implantable VNS Device
9.5.2. External VNS Device
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
9.6.1. Metallic
9.6.2. Ceramics
9.6.3. Polymeric
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
9.7.1. Epilepsy
9.7.2. Depression
9.7.3. Migraine
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
10.3.1. By Country
10.3.2. By Product
10.3.3. By Biomaterial
10.3.4. By Application
10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
10.5.1. Implantable VNS Device
10.5.2. External VNS Device
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
10.6.1. Metallic
10.6.2. Ceramics
10.6.3. Polymeric
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
10.7.1. Epilepsy
10.7.2. Depression
10.7.3. Migraine
10.8. Market Attractiveness Analysis
11. Latin America Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
11.3.1. By Country
11.3.2. By Product
11.3.3. By Biomaterial
11.3.4. By Application
11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
11.5.1. Implantable VNS Device
11.5.2. External VNS Device
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
11.6.1. Metallic
11.6.2. Ceramics
11.6.3. Polymeric
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
11.7.1. Epilepsy
11.7.2. Depression
11.7.3. Migraine
11.8. Market Attractiveness Analysis
12. Middle East & Africa Vagus Nerve Stimulation Market Outlook: Historical (2019-2023) and Forecast (2024-2031)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
12.3.1. By Country
12.3.2. By Product
12.3.3. By Biomaterial
12.3.4. By Application
12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
12.4.1. GCC Countries
12.4.2. Egypt
12.4.3. South Africa
12.4.4. Northern Africa
12.4.5. Rest of Middle East & Africa
12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
12.5.1. Implantable VNS Device
12.5.2. External VNS Device
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Biomaterial, 2024-2031
12.6.1. Metallic
12.6.2. Ceramics
12.6.3. Polymeric
12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
12.7.1. Epilepsy
12.7.2. Depression
12.7.3. Migraine
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2023
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Soterix Medical Inc.
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. MicroTransponder Inc
13.3.3. Beijing PINS Medical Co., Ltd
13.3.4. LivaNova PLC
13.3.5. Neuropix Company Ltd.
13.3.6. Parasym Ltd
13.3.7. electroCore, Inc.
13.3.8. tVNS Health GmbH
13.3.9. SetPoint Medical Corporation
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations